Zoetis Inc. (NYSE:ZTS) Stock Position Raised by Tokio Marine Asset Management Co. Ltd.

Tokio Marine Asset Management Co. Ltd. lifted its stake in shares of Zoetis Inc. (NYSE:ZTS) by 0.8% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 126,469 shares of the company’s stock after purchasing an additional 942 shares during the period. Zoetis makes up about 1.1% of Tokio Marine Asset Management Co. Ltd.’s holdings, making the stock its 17th biggest position. Tokio Marine Asset Management Co. Ltd.’s holdings in Zoetis were worth $24,710,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Metis Global Partners LLC boosted its position in Zoetis by 4.9% during the 3rd quarter. Metis Global Partners LLC now owns 32,187 shares of the company’s stock worth $6,289,000 after acquiring an additional 1,511 shares during the period. Zions Bancorporation N.A. increased its stake in Zoetis by 11.8% in the 3rd quarter. Zions Bancorporation N.A. now owns 21,036 shares of the company’s stock valued at $4,110,000 after buying an additional 2,219 shares during the period. KBC Group NV lifted its position in Zoetis by 3.9% in the 3rd quarter. KBC Group NV now owns 375,167 shares of the company’s stock worth $73,300,000 after buying an additional 14,159 shares in the last quarter. Huntington National Bank boosted its stake in shares of Zoetis by 5.8% during the 3rd quarter. Huntington National Bank now owns 249,247 shares of the company’s stock valued at $48,698,000 after buying an additional 13,757 shares during the period. Finally, Plato Investment Management Ltd increased its stake in shares of Zoetis by 13.2% in the third quarter. Plato Investment Management Ltd now owns 8,088 shares of the company’s stock worth $1,579,000 after acquiring an additional 943 shares during the last quarter. Institutional investors and hedge funds own 92.80% of the company’s stock.

Analyst Ratings Changes

A number of brokerages recently weighed in on ZTS. BTIG Research raised their price objective on Zoetis from $220.00 to $225.00 and gave the company a “buy” rating in a research note on Monday, August 12th. Stifel Nicolaus lifted their target price on Zoetis from $200.00 to $210.00 and gave the stock a “buy” rating in a research report on Wednesday, September 18th. Piper Sandler upped their price target on Zoetis from $195.00 to $210.00 and gave the company an “overweight” rating in a report on Wednesday, August 14th. JPMorgan Chase & Co. lifted their price objective on Zoetis from $225.00 to $230.00 and gave the stock an “overweight” rating in a report on Friday, October 11th. Finally, Argus upgraded Zoetis to a “strong-buy” rating in a research note on Friday, August 9th. Ten analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus target price of $221.44.

Zoetis Trading Down 1.2 %

Zoetis stock traded down $2.17 during mid-day trading on Thursday, hitting $174.87. The stock had a trading volume of 118,595 shares, compared to its average volume of 2,530,994. The stock has a 50-day simple moving average of $187.61 and a two-hundred day simple moving average of $180.02. The company has a current ratio of 3.69, a quick ratio of 2.27 and a debt-to-equity ratio of 1.26. The stock has a market capitalization of $78.90 billion, a PE ratio of 33.32, a P/E/G ratio of 2.67 and a beta of 0.90. Zoetis Inc. has a 12 month low of $144.80 and a 12 month high of $201.92.

Zoetis (NYSE:ZTS) last posted its quarterly earnings results on Monday, November 4th. The company reported $1.58 earnings per share for the quarter, topping analysts’ consensus estimates of $1.46 by $0.12. The business had revenue of $2.40 billion during the quarter, compared to the consensus estimate of $2.29 billion. Zoetis had a net margin of 26.55% and a return on equity of 51.98%. Zoetis’s revenue for the quarter was up 11.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.36 earnings per share. As a group, sell-side analysts forecast that Zoetis Inc. will post 5.9 EPS for the current year.

Zoetis Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 3rd. Shareholders of record on Thursday, October 31st will be paid a $0.432 dividend. This represents a $1.73 annualized dividend and a yield of 0.99%. The ex-dividend date is Thursday, October 31st. Zoetis’s payout ratio is 32.52%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.